Panorama Capital invests in passionate entrepreneurs building leading companies in life sciences and technology.
Business Model:
Revenue: $5.8M
Employees: 51-200
Address: 1999 S Bascom Avenue Suite 700
City: Campbell
State: CA
Zip: 95008
Country: US
Panorama Capital invests in passionate entrepreneurs building leading companies in life sciences and technology. Founded in 2005 as the successor to the venture capital program of JPMorgan Partners, they take a hands on, highly collaborative approach to investing, bringing to bear the team&s;s extensive operating and investing experience to each portfolio company. The firm is managed by a seasoned group of life sciences and technology investors who collectively possess over 140 years of investment and industry experience. In addition to their extensive investing experience, they possesses broad experience as executives, entrepreneurs, engineers, and physicians. This collective experience gives Panorama Capital a powerful combination of technical, entrepreneurial, operational, and transactional expertise to help foster the development of their portfolio companies.
Contact Phone:
+16502341420
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
2/2021 | AkroStar | Seed Round | 61.9M |
5/2008 | CHiL Semiconductor | Series C | 16.7M |
7/2010 | Validity Sensors | Series D | 0 |
10/2012 | WGT Media | Venture Round | 1M |
8/2010 | NinthDecimal | Debt Financing | 2.1M |
10/2012 | Validity Sensors | Series E | 10M |
7/2009 | Narus | Venture Round | 8.7M |
8/2007 | Presidio Pharmaceuticals | Series B | 26M |
7/2011 | PowerVision | Series C | 24M |
7/2008 | Shopflick | Series A | 7M |
9/2009 | Vinfolio | Series A | 4.5M |
5/2007 | LV Sensors | Series B | 15M |
9/2006 | Vyatta | Series A | 7.5M |
3/2010 | WGT Media | Series C | 10M |
2/2013 | CardioKinetix | Series E | 4M |
10/2006 | BelAir Networks | Series D | 21.4M |
11/2011 | Fixmo | Series C | 23M |
6/2009 | Hyperion Therapeutics | Series C | 60M |
5/2021 | AkroStar | Series A | 77.7M |
5/2011 | NinthDecimal | Venture Round | 20M |
12/2008 | NinthDecimal | Series B | 11.1M |
6/2009 | Vyatta | Series C | 0 |
5/2008 | WGT | Series B | 10M |
11/2012 | Auspex Pharmaceuticals | Series D | 0 |
1/2014 | Auspex Pharmaceuticals | Series E | 0 |
12/2017 | NinthDecimal | Series E | - |
12/2007 | BelAir Networks | Series E | 17.5M |
8/2022 | Jinyuansheng | Series B | 147.6M |
3/2013 | CardioKinetix | Series E | 23M |
9/2006 | Aristos Logic | Series F | 15M |
1/2011 | NextWave Pharmaceuticals | Series C | 45M |
11/2011 | Beyond the Rack | Series B | 0 |
9/2006 | Alvine Pharmaceuticals | Series A | 21.5M |
6/2011 | Fixmo Carrier Services | Series B | 6.5M |
11/2007 | Zilliant | Series F | 0 |
8/2009 | Cadent | Venture Round | 19.3M |
11/2013 | Beyond the Rack | Series C | 0 |
7/2012 | 33Across | Series C | 13.1M |
4/2010 | Tynt | Series B | 8M |
12/2014 | CardioKinetix | Series F | 0 |
10/2012 | Presidio Pharmaceuticals | Venture Round | 8M |
5/2013 | Zoove | Series E | 0 |
10/2007 | GridNetworks | Series A | 9.5M |
10/2012 | Skyfire Labs, Inc. | Series D | 10M |
8/2011 | Zoove | Series D | 0 |
6/2011 | Fixmo | Series B | 6.5M |
5/2021 | AkroStar | Series A | 0 |
2/2021 | AkroStar | Seed Round | 0 |
12/2017 | NinthDecimal | Series E | - |
12/2014 | CardioKinetix | Series F | 0 |
1/2014 | Auspex Pharmaceuticals | Series E | 0 |
11/2013 | Beyond the Rack | Series C | 0 |
5/2013 | Zoove | Series E | 0 |
3/2013 | CardioKinetix | Series E | 0 |
2/2013 | CardioKinetix | Series E | 0 |
11/2012 | Auspex Pharmaceuticals | Series D | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|